Stereotactic body radiotherapy in extracranial oligometastatic or oligoprogressive breast cancer

被引：0
|
作者：
Weykamp, F. [1 ]
Koenig, L. [1 ]
Seidensaal, K. [1 ]
Forster, T. [1 ]
Hoegen, P. [1 ]
Akbaba, S. [1 ]
Susko, M. [2 ]
Schneeweiss, A. [3 ]
Debus, J. [1 ]
Hoerner-Rieber, J. [1 ]
机构：
[1] Heidelberg Univ Hosp, Dept Radiat Oncol, Heidelberg, Germany
[2] Univ Calif San Francisco, Dept Radiat Oncol, San Francisco, CA USA
[3] Natl Ctr Tumor Dis, Ctr Gynecol Oncol, Heidelberg, Germany
来源：
RADIOTHERAPY AND ONCOLOGY | 2020年 / 152卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PO-0969
引用
收藏
页码：S516 / S517
页数：2
相关论文
共 50 条
  • [31] Can we predict response after stereotactic body radiotherapy in oligometastatic breast cancer?
    Graupner, Donata
    Rembak-Szynkiewicz, Justyna
    Kulik, Roland
    Grzadziel, Aleksandra
    Latusek, Tomasz
    Nowicka, Elzbieta
    Gabrys, Dorota
    RADIOTHERAPY AND ONCOLOGY, 2024, 194 : S725 - S726
  • [32] Clinical Outcomes for Stereotactic Ablative Radiotherapy in Oligometastatic and Oligoprogressive Gynecological Malignancies
    Mesko, Shane
    Sandler, Kiri
    Cohen, Joshua
    Konecny, Gottfried
    Steinberg, Michael
    Kamrava, Mitchell
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2017, 27 (02) : 403 - 408
  • [33] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Reem Alomran
    Michelle White
    Melissa Bruce
    Mathias Bressel
    Susan Roache
    Lama Karroum
    Gerard G. Hanna
    Shankar Siva
    Shom Goel
    Steven David
    BMC Cancer, 21
  • [34] Stereotactic radiotherapy for oligoprogressive ER-positive breast cancer (AVATAR)
    Alomran, Reem
    White, Michelle
    Bruce, Melissa
    Bressel, Mathias
    Roache, Susan
    Karroum, Lama
    Hanna, Gerard G.
    Siva, Shankar
    Goel, Shom
    David, Steven
    BMC CANCER, 2021, 21 (01)
  • [35] Stereotactic Body Radiotherapy for Oligometastatic Disease
    Hanna, G. G.
    Landau, D.
    CLINICAL ONCOLOGY, 2015, 27 (05) : 290 - 297
  • [36] Delivery of Concurrent Extracranial Stereotactic Body Radiotherapy with Osimertinib for Oligoprogressive EGFR Mutated Stage IV NSCLC
    Tsur, E.
    Michaeli, T.
    Nechushtan, H.
    Rotenberg, Y.
    Blumenfeld, P.
    JOURNAL OF THORACIC ONCOLOGY, 2022, 17 (09) : S129 - S129
  • [37] Stereotactic Body Radiotherapy for Oligometastatic Prostate Cancer: Where is the Evidence?
    Macbeth, F. R.
    Abratt, R. P.
    CLINICAL ONCOLOGY, 2021, 33 (01) : E94 - E94
  • [38] Stereotactic body radiotherapy for bone oligometastatic disease in prostate cancer
    Priyanka H. Patel
    Cheng Lee Chaw
    Alison C. Tree
    Mansour Sharabiani
    Nicholas J. van As
    World Journal of Urology, 2019, 37 : 2615 - 2621
  • [39] Stereotactic Body Radiotherapy (SBRT) in oligometastatic prostate cancer patients
    Chaw, C. L.
    Henderson, D.
    Khoo, V.
    Tree, A.
    Eeles, R.
    Van As, N.
    RADIOTHERAPY AND ONCOLOGY, 2016, 119 : S209 - S209
  • [40] Repeated stereotactic body radiotherapy for oligometastatic prostate cancer recurrence
    Decaestecker, Karel
    De Meerleer, Gert
    Lambert, Bieke
    Delrue, Louke
    Fonteyne, Valerie
    Claeys, Tom
    De Vos, Filip
    Huysse, Wouter
    Hautekiet, Arne
    Maes, Gaethan
    Ost, Piet
    RADIATION ONCOLOGY, 2014, 9
12345